In Biology, Polarization Is A Good Thing

Many cell types acquire asymmetry for their biological function. Yeast cells, worms, mice and men all use the same cellular compass, made up of a combination of protein complexes that is essential for the spatial orientation of the cell. The Par-Tiam1 polarity complex is a crucial component of the compass. Tiam1 was earlier identified as a gene that could influence dissemination of tumour cells.

In a previous study by the group of John Collard from the NKI-AVL, it became clear that the Par-Tiam1 complex is crucial for top/bottom orientation of adherent cells. This form of cell asymmetry is required for the cells to properly adhere and to form a tightly connected cellular structure. However, loss of orientation or cell polarity leads dissociation of cell-cell contacts and in tumours to dissemination of cancer cells.

Now it appears that the Par-Tiam1 complex also controls front-rear orientation of the cell. This way cells that leave their brethrens behind after detaching know how to find their way while migrating. Collard and colleagues showed that mouse skin cells with a functional compass migrate in a straight linear fashion toward their target. The cells persistently move forward like a caterpillar, continuously expanding and retracting in one direction. But when the Par-Tiam1 complex is disrupted or shut-down, the cells migrate aimlessly in random direction.

Pegtel & Collard: “It is becoming clear that polarity of cells is crucial for embryonic development and function of many biological processes in humans and lower organisms alike. It guides immune cells to sites of infection and directs the organization of the neuronal network. But at the same time, it also prevents detachment of adherent cells; we were very surprised that one protein complex regulates such seemingly opposing tasks”. This could explain the findings that Tiam1 is able both to promote and prevent metastasis in different tumours.

Details of this study led by scientists Michiel Pegtel and John Collard from the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) in the Netherlands are published in the October 9th issue of the scientific journal Current Biology.